Received Feb 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 9R5LC | — |
administered a dose of Havrix which had a November 2024 expiration date; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 6-year-old female patient who received HAV (Havrix) (batch number 9R5LC, expiry date 02-NOV-2024) for prophylaxis. Previously administered products included Havrix (1st dose on unknown date). On 23-JAN-2025, the patient received the 2nd dose of Havrix. On 23-JAN-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: administered a dose of Havrix which had a November 2024 expiration date). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 24-JAN-2025 Other HCP reported that a 6 year old female patient was administered a dose of Havrix which had a November 2024 expiration date, which led to expired vaccine used. Reporter stated that this was the patient's second dose in the series. Also, at the time of reporting, a repeat dose has not been administered.